EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders

Ludovica Franceschin, Alessia Guidotti, Roberto Mazzetto iD, Jacopo Tartaglia iD, Christian Ciolfi iD, Mauro Alaibac, Alvise Sernicola iD

Biomolecules · 2024

DOI: 10.3390/biom14121515 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Ludovica Franceschin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy. Hauptthemen laut MEDLINE: Neutrophils, Drug Repositioning, Skin Diseases, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophil-mediated inflammation is a key feature of immune-mediated chronic skin disorders, but the mechanistic understanding of neutrophil involvement in these conditions remains incomplete. Dapsone, colchicine, and tetracyclines are established drugs within the dermatologist’s therapeutic armamentarium that are credited with potent anti-neutrophilic effects. Anti-neutrophilic drugs have established themselves as versatile agents in the treatment of a wide range of dermatological conditions. Some of these agents are approved for the management of specific dermatologic conditions, but most of their current uses are off-label and only supported by isolated reports or case series. Their anti-inflammatory and immunomodulatory properties make them particularly valuable in managing auto-immune bullous diseases, neutrophilic dermatoses, eosinophilic dermatoses, interface dermatitis, and granulomatous diseases that are the focus of this review. By inhibiting inflammatory pathways, reducing cytokine production, and modulating immune responses, they contribute significantly to the treatment and management of these complex skin conditions. Their use continues to evolve as our understanding of these diseases deepens, and they remain a cornerstone of dermatological therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsDrug RepositioningSkin DiseasesInflammationHumansAnti-Inflammatory AgentsColchicineDapsoneAnimals

Stichwörter der Autor:innen

autoimmune bullous disorderscolchicinedapsonehidradenitis suppurativaneutrophilspsoriasispyoderma gangrenosumtetracycline

Substanzen

Anti-Inflammatory AgentsColchicineDapsone

Autor:innen und Institutionen

  • Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy.

ORCID-Profile: Roberto Mazzetto, Jacopo Tartaglia, Christian Ciolfi, Alvise Sernicola

Zitieren

APA

Franceschin, L., Guidotti, A., Mazzetto, R., Tartaglia, J., Ciolfi, C., Alaibac, M., & Sernicola, A. (2024). Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders. Biomolecules. https://doi.org/10.3390/biom14121515

Vancouver

Franceschin L, Guidotti A, Mazzetto R, Tartaglia J, Ciolfi C, Alaibac M, et al. Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders. Biomolecules. 2024. doi:10.3390/biom14121515

BibTeX
@article{Franceschin2024,
  author = {Franceschin, Ludovica and Guidotti, Alessia and Mazzetto, Roberto and Tartaglia, Jacopo and Ciolfi, Christian and Alaibac, Mauro and Sernicola, Alvise},
  title = {Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14121515}
}
Kostenlos starten →